Nature versus urban hiking for Veterans with post-traumatic stress disorder: a pilot randomised trial conducted in the Pacific Northwest USA.

OBJECTIVES: To evaluate feasibility and acceptability of a group-based nature recreation intervention (nature hiking) and control condition (urban hiking) for military Veterans with post-traumatic stress disorder (PTSD). DESIGN AND SETTING: A pilot randomised controlled trial conducted in the US Pacific Northwest. PARTICIPANTS: Veterans with PTSD due to any cause. INTERVENTIONS: Twenty-six participants were randomised to a 12-week intervention involving either six nature hikes (n=13) or six urban hikes (n=13). PRIMARY AND SECONDARY OUTCOME MEASURES: Feasibility was assessed based on recruitment, retention and attendance. Questionnaires and postintervention qualitative interviews were conducted to explore intervention acceptability. Questionnaires assessing acceptability and outcomes planned for the future trial (eg, PTSD symptoms) were collected at baseline, 6 weeks, 12 weeks (immediately after the final hike) and 24 weeks follow-up. RESULTS: Of 415 people assessed for eligibility/interest, 97 were interested and passed preliminary eligibility screening, and 26 were randomised. Mean completion of all questionnaires was 91% among those in the nature hiking group and 68% in those in the urban hiking group. Over the course of the intervention, participants in the nature and urban groups attended an average of 56% and 58%, respectively, of scheduled hikes. Acceptability of both urban and nature hikes was high; over 70% reported a positive rating (ie, good/excellent) for the study communication, as well as hike locations, distance and pace. Median PTSD symptom scores (PTSD Checklist-5) improved more at 12 weeks and 24 weeks among those in the nature versus urban hiking group. CONCLUSIONS: This pilot study largely confirmed the feasibility and acceptability of nature hiking as a potential treatment for Veterans with PTSD. Adaptations will be needed to improve recruitment and increase hike attendance for a future randomised controlled trial to effectively test and isolate the ways in which nature contact, physical activity and social support conferred by the group impact outcomes. TRIAL REGISTRATION NUMBER: NCT03997344.

A Hepatitis C Educational Needs Assessment of Canadian Healthcare Providers.

Background and Aim. Despite advances in the treatment of chronic hepatitis C infection (CHC), it remains a major public health problem in Canada and globally. The knowledge of healthcare providers (HCPs) is critical to improve the care of CHC in Canada. To assess the current knowledge and educational needs of healthcare providers (HCPs) in the area of CHC management a national online survey was conducted. Method. An interprofessional steering committee designed a 29-question survey distributed through various direct and electronic routes. The survey assessed several domains (e.g., participant and practice demographics, access to resources, knowledge of new treatments, and educational preferences). Results. A total of 163 HCPs responded to the survey. All hepatologists and 8% of primary care providers (PCPs) reported involvement in treatment of CHC. Physicians most frequently screened patients who had abnormal liver enzymes, while nurses tended to screen based on lifestyle factors. More than 70% of PCPs were not aware of new medications and their mechanisms. Conclusion. Overall, the needs assessment demonstrated that there was a need for further education, particularly for primary care physicians, to maximize the role that they can play in screening, testing, and treatment of hepatitis C in Canada.

Seroprevalences of hepatitis B virus and hepatitis C virus among participants of an Asian health fair in the Lower Mainland, British Columbia.

BACKGROUND: The seroprevalences of hepatitis B virus (HBV) and hepatitis C virus (HCV) are 0.4% and 0.8%, respectively, in Canada, but varying rates have been reported in different populations. OBJECTIVES: To determine the seroprevalences of HBV and HCV among attendees of an Asian health fair in the Lower Mainland, British Columbia, as well as to correlate questionnaire answers regarding vaccination status to serological profiles. METHODS: Attendees at an Asian health fair were invited to participate in the present study on a voluntary basis. They provided answers to a questionnaire including ethnicity and vaccination status. Blood was then drawn for HBV and HCV serology. Active HBV was defined as HBV surface antigen (HBsAg) positive while HCV seroprevalence was defined as HCV antibody reactive. Previous exposure to HBV was defined as HBV core antibody (anti-HBc) positive and HBsAg negative. Nonimmunity was defined as anti-HBc negative and HBV surface antibody negative. Only those with correct demographic information matched to serological results were included in the study. RESULTS: There were 192 consenting attendees of the fair, of whom 112 were included in the study. Of the participants, 91% were Chinese. Active HBV infection was found in three participants (2.7% [95% CI 0.6% to 7.6%]) and HCV infection was found in two participants (1.8% [95% CI 0.2% to 6.3%]). More than 40% of participants had been previously exposed to HBV (42% [95% CI 33% to 51%]). Almost 20% demonstrated nonimmunity to HBV (19% [95% CI 12% to 27%]). There was significant discordance when questionnaire answers regarding vaccination status were compared with serological profiles. CONCLUSION: The seroprevalences of HBV and HCV in this cohort were 2.7% and 1.8%, respectively - higher than nationally reported rates. Our results highlight that the lack of knowledge of HBV infection and vaccination status remains a significant clinical issue in the Asian community of British Columbia.

HISTORIQUE: La séroprévalence des virus de l'hépatite B (VHB) et de l'hépatite C (VHC) s'élève à 0,4 % et à 0,8 %, respectivement, au Canada, mais les taux sont variables dans diverses populations. OBJECTIFS: Déterminer la séroprévalence du VHB et du VHC chez les participants à une foire asiatique sur la santé du Lower Mainland, en Colombie-Britannique, et lier les réponses au questionnaire sur le statut vaccinal avec les profils sérologiques. MÉTHODOLOGIE: Les participants à une foire asiatique sur la santé ont été invités à participer volontairement à l'étude. Ils ont répondu à un questionnaire contenant des questions sur l'ethnie et le statut vaccinal. Du sang a ensuite été prélevé en vue d'une sérologie du VHB et du VHC. Le VHB actif était défini comme un résultat positif à l'antigène de surface du VHB (AgHBs), tandis que la séroprévalence du VHC était définie comme une réaction aux anticorps anti-VHC. Une exposition passée au VHB était définie comme un résultat positif à l'antigène capsidique du VHB (anti-HBc) et négatif à l'AgHBs. La non-immunité était définie comme des résultats négatifs à l'anti-HBc et à l'anticorps de surface du VHB. Seulement ceux dont l'information démographique exacte correspondait aux résultats sérologiques ont participé à l'étude. RÉSULTATS: Au total, 192 participants consentants ont participé à la foire, dont 112 à l'étude. Des participants, 91 % étaient Chinois. Trois étaient atteints d'une infection active par le VHB (2,7 % [95 % IC 0,6 % à 7,6 %]) et deux, d'une infection par le VHC (1,8 % [95 % IC 0,2 % à 6,3 %]). Plus de 40 % des participants avaient déjà été exposés au VHB (42 % [95 % IC 33 % à 51 %]). Près de 20 % ont démontré une non-immunité au VHB (19 % [95 % IC 12 % à 27 %]). On constatait une importante discordance entre les réponses au questionnaire sur le statut vaccinal et les profils sérologiques. CONCLUSION: La séroprévalence du VHB et le VHC de cette cohorte s'élevait à 2,7 % et à 1,8 %, respectivement, soit des résultats plus élevés que les taux nationaux. Ces résultats font ressortir que l'absence de connaissances sur l'infection par le VHB et le statut vaccinal demeure un problème clinique significatif dans la communauté asiatique de la Colombie-Britannique.

Suicide: the unmet challenge of the trauma system.

HYPOTHESIS: We hypothesized that a significant number of injuries and deaths due to suicide occurred in patients undergoing psychiatric treatment. DESIGN: We performed a retrospective cohort study of patients who committed suicide and patients with intentional self-inflicted injury. SETTING: San Francisco General Hospital in San Francisco, Calif, and the San Francisco Violent Injury Reporting System. PATIENTS: We retrospectively reviewed the San Francisco General Hospital records for all attempted and fatal suicides during calendar years 2001 and 2002. Data were merged with suicide data collected by the San Francisco Violent Injury Reporting System. RESULTS: Two hundred thirty-five suicides occurred between January 1, 2001, and December 31, 2002. One hundred thirty-two patients (56%) who committed suicide had a known mental health disorder at the time of their suicide. One hundred fifteen (87.1%) of those with a known mental health disorder had received psychiatric treatment at some point. Ninety-one patients (68.9%) with a known mental health disorder who committed suicide were receiving psychiatric treatment at the time of suicide. One hundred sixty-five (70%) of those who committed suicide had a traumatic mechanism of death. During the same 2-year period, 3106 trauma patients were admitted to San Francisco General Hospital. Fifty-five (2%) sustained intentional self-inflicted injuries. Ten (18%) of the 55 patients with intentional self-inflicted injury died after arrival at San Francisco General Hospital. CONCLUSION: Creation of a feedback mechanism between the trauma and mental health systems has the potential to improve psychiatric care and prevent injury and death.